Impact of Estrogen on TGF-β Signaling in Cervical Cancer
Author Information
Author(s): Jose Diaz-Chavez, Rogelio Hernandez-Pando, Paul F Lambert, Patricio Gariglio
Primary Institution: Centro de Investigación y de Estudios Avanzados, México
Hypothesis
Does estrogen influence the expression of TGF-βRII in cervical cancer?
Conclusion
The study suggests that estrogen and the E7 oncogene work together to reduce TGF-βRII expression, which may contribute to cervical cancer development.
Supporting Evidence
- Estrogen treatment increased TGF-β2 mRNA levels in cervical tissues.
- TGF-βRII expression was significantly lower in estrogen-treated K14-E7 mice.
- Cervical cancer developed in 100% of estrogen-treated K14-E7 mice.
Takeaway
This study found that estrogen can help cause cervical cancer by lowering a protein that usually helps control cell growth.
Methodology
The study used in situ RT-PCR, real-time PCR, and immunohistochemistry to analyze TGF-β2 and TGF-βRII expression in cervical tissues from transgenic and nontransgenic mice.
Limitations
The study is limited to a mouse model and may not fully represent human cervical cancer.
Participant Demographics
Transgenic mice expressing HPV16 E7 and nontransgenic control mice.
Statistical Information
P-Value
p<0.005
Statistical Significance
p<0.005
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website